Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,591,319
+$6,354,461 QoQ
Shares Held
1,557,466
0.0% QoQ
Ownership
0.834%
of shares outstanding
% of Portfolio
3.27%
of 13F equity value
Holder Rank
#31
of 245 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vivo Capital, LLC holds $1,052,388,129 across 43 Biotechnology names. DYN ranks #11 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $95,015,558 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
271,116 | $90,766,925 | |
| 3 | ERAS |
Erasca, Inc.
|
4,127,412 | $75,614,187 | |
| 4 | AVBP |
ArriVent BioPharma, Inc.
|
1,682,097 | $58,436,049 | |
| 5 | ABVX |
Abivax S.A.
|
414,899 | $55,289,440 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
1,379,769 | $43,131,578 | |
| 7 | CRVS |
Corvus Pharmaceuticals, Inc.
|
2,805,816 | $41,918,891 | |
| 8 | DRUG |
Bright Minds Biosciences Inc.
|
557,172 | $39,113,474 |
All Filings in DYN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,591,319 | 1,557,466 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,236,858 | 1,557,466 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $51,148,617 | 2,614,960 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,079,244 | 2,614,960 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,614,419 | 1,114,960 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,662,481 | 1,114,960 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $26,268,457 | 1,114,960 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $40,049,363 | 1,114,960 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $57,703,949 | 1,635,136 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $46,421,511 | 1,635,136 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $13,767,308 | 1,035,136 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,274,818 | 1,035,136 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,498,472 | 577,642 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,654,435 | 577,642 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,694,870 | 577,642 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,336,053 | 577,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,968,400 | 577,642 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,568,468 | 577,642 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,868,163 | 577,642 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,380,906 | 577,642 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,153,587 | 577,642 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,970,780 | 577,642 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,615,000 | 315,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,359,850 | 315,000 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||